viernes, 27 de septiembre de 2019

Laser Ablation: Stop Seizures: and More

Marketing

PHILADELPHIA, Pa. (Ivanhoe Newswire) — More than 50 million people worldwide have epilepsy. For some, medication controls the onset of seizures.  Others need major surgery, and for some, laser ablation is the solution, but there have been no guidelines for doctors to determine how much ablation is just enough to be effective.



DENVER, Colo. (Ivanhoe Newswire) — Imagine, the faster you grow, the faster your spine curves. That’s what happens when you’re a child with scoliosis.



NEW YORK CITY, N.Y. (Ivanhoe Newswire) — Nasal congestion can be treated with over- the- counter medication, prescription drugs, or even surgery as a last resort. But now, an FDA- approved therapy means patients can be treated in the doctor’s office and avoid the unpleasant side effects and recovery time of an invasive treatment.



PHOENIX, Ariz. (Ivanhoe Newswire) — What if your surgeon could practice your procedure before going into the operating room? An innovation team in Phoenix, Arizona is 3D- printing the spines of patients who have severe scoliosis so there are no surprises on operation day.



ORLANDO, Fla. (Ivanhoe Newswire) – Fruits, veggies, salads and even trail mix are a few of the foods that people eat in order to add a little flavor into their diet. But with all that hard work, are the snacks you are choosing getting you closer to your goal or making the road longer?





Doctor's In-depth Interview of the week

Blood Test Diagnoses Stroke Fast 
Maha Sallam, PhD, President of VuEssence
Tampa, Florida


Quote of the week:

America did not conquer the West through superior technology, nor did it demonstrate the advantages of democracy. America “won” the West by blood, brutality, and terror.” 

— 
David Treuer





If you know of an innovative medical treatment, send us the name of the treatment,  name of the doctor and city. We may be able to cover it in one of our series: newsalert@ivanhoe.com

Website Informationwebdoctor@ivanhoe.com

Content Licensing: jcherry@ivanhoe.com

No hay comentarios:

Publicar un comentario